Generation of a virus‐like particles based vaccine against IgE

Background: Anti‐IgE immunotherapy with monoclonal antibodies represents a breakthrough in treatment of severe allergic diseases. However, drawbacks such as short half‐life and high price are not negligible. Our objective is to develop an anti‐IgE vaccine based on virus‐like particles (VLPs) which c...

Cijeli opis

Bibliografski detalji
Glavni autori: Gharailoo, Z, Plattner, K, Augusto, G, Engeroff, P, Vogel, M, Bachmann, MF
Format: Journal article
Jezik:English
Izdano: Wiley 2024